baber/WOPTO huggingface dataset:
Patent AU-742707-B2 (AU)
Title: Light alloy thread-forming screw and its production method
Inventor: FRIEDERICH HEINRICH
IPC: F16B25/00
Filed: 1999-08-12
Granted: 2002-01-10
Abstract: The invention provides a self-screwthread-forming screw comprising an artificially ageable light metal alloy as the screw material, whose shank is provided with a screwthread having screwthread flanks, and which is distinguished in that in at least one region of the screw by virtue of a differing heat treatment the material has a different structure from in the rest of the screw. The invention also provides a process for the production of a screw having the following process steps: forming the screw by rolling or cutting production of the screwthread geometry, solution heat treatment of the screw, quenching of the screw in water, and artificial ageing of the screw, in which the screw if subjected to differing heat treatment in various portions thereof.
Patent AU-659970-B2 (AU)
Title: Vasoocclusion coil with woven fibrous tubular covering
Inventor: PHELPS JAMES J
IPC: A61F2/01
Filed: 1993-10-26
Granted: 1995-06-01
Abstract: This invention is in the field of vasoocclusion devices. More particularly, it relates to a vasoocclusion coil which may be segmented, onto which a fibrous, woven or braided, tubular covering or element is attached.
Patent AU-594047-B2 (AU)
Title: Improvements in or relating to a process for purifying growth hormone-like materials
Inventor: GRINNAN EDWARD LEONARD
IPC: C07G15/00
Filed: 1986-04-04
Granted: 1990-03-01
Abstract: A process is provided for separating impurities from an impure mixture containing growth hormone-like material, which comprises:
 (1) applying said mixture to a reverse phase macroporous acryulate ester copolymer resin support at a pH of from about 7 to about 9; and
 (2) eluting said growth hormone-like material from said support with an aqueous eluant having a pH of from about 7 to about 9 and containing from about 20% to about 80% by volume of an organic diluent selected from the group consisting of acetone, acetonitrile, and a combination of acetone and acetonitrile.
Patent AU-644083-B2 (AU)
Title: Crystalline R-H-GM-CSF and method for the preparation
Inventor: REICHERT PAUL
IPC: C07K14/52
Filed: 1990-06-04
Granted: 1993-12-02
Abstract: A method of preparing a crystalline form of recombinant human granulocyte-macrophage colony-stimulating factor (r-h-GM-CSF) using polyethylene glycol with molecular weight of about 8000.
Patent AU-643447-B2 (AU)
Title: Novel carboxamide non-ionic contrast media
Inventor: SOVAK MILOS DR
IPC: C07C233/88
Filed: 1990-07-04
Granted: 1993-11-18
Abstract: Triiodo-5-aminoisophthalamides in which the amino and one of the amide nitrogen groups are substituted are indicated. The compounds have at least two hydroxyl groups and low viscosity and osmolality. Processes for the preparation of the compounds are indicated.
Patent AU-583388-B2 (AU)
Title: High performance liquid chromatography mobile phase
Inventor: POLL DICK JACOB
IPC: G01N30/34
Filed: 1986-06-23
Granted: 1989-04-27
Abstract: There is described a mobile phase for use in the purification of proteins using reversed phase HPLC on a preparative scale. The mobile phase is an aqueous solution containing .005 to 1 M of a physiologically acceptable acid of the general formula YCOOH where Y is a polar electron withdrawing group capable of hydrogen bonding silanol groups. The solution also contains up to 95% V of a physiologically acceptable organic solvent. A preparative method of purifying proteins such as HSA or BSA using reversed phase HPLC is also described.
Patent AU-632606-B2 (AU)
Title: Apparatus for the slicing of fruit, vegetables or the like
IPC: B26D3/28
Filed: 1990-08-06
Granted: 1993-01-07
Abstract: The invention is directed to a device for cutting fruit, vegetables or the like into slices, comprising a blade-holding plate at whose leading edge a V-shaped cutter blade is arranged, comprising two framing ledges arranged essentially parallel that are connected to one another by the blade-holding plate and by at least one further transverse web, and comprising a slide plate guided at the framing ledges and introducible parallel to the blade-holding plate, whereby a narrow gap remains between the back edge of the slide plate and the cutter blade. It is inventively provided that a support plate (11) fashioned as a closed surface is arranged under the slide plate (6) in order to increase the stability of the slide plate, particularly to counter sagging when pressure is exerted on the material to be cut.
Patent AU-674569-B2 (AU)
Title: Quinoline derivative
Inventor: KIMURA TOMIO
IPC: C07D405/12
Filed: 1994-02-16
Granted: 1997-01-02
Abstract: A compound (quinoline derivative) represented by general formula (I) and having such a potent leucotriene antagonism that it is significantly useful as an antiallergic and an anti-inflammatory. <CHEM>
Patent AU-702581-B2 (AU)
Title: Requisite for reducing emissions of side stream smoke from a cigarette
Inventor: ELST GABRIEL VAN DER
IPC: A24D1/12
Filed: 1996-06-10
Granted: 1999-02-25
Abstract: A smoker's requisite for reducing the amount of smoke given off by the smouldering tip of a cigarette. The requisite consists of a rigid sleeve that may be slid along a cigarette and momentarily positioned over the smouldering tip thereof then withdrawn to enable the smoker to take a puff from the opposite end in a conventional way. The sleeve advantageously comprises a finger engaging gripping and supporting portion providing ventilation of the cigarette body, and a briar wood portion designed to be controllably moved over the smouldering tip.
Patent AU-648987-B2 (AU)
Title: Golf training aid/simulator
Inventor: ASHTON JAMES TERENCE
IPC: A63B69/36
Filed: 1990-08-09
Granted: 1994-05-12
Abstract: The aid/simulator provides an improvement in known equipment to enable the user to simulate a range of shots he can expect during a round of golf. According to this invention, the aid/simulator comprises a base (1) providing a standing area (4) on which the user takes his stance in relation to a ball playing area (3) which is characterised by the base including a platform (2) adjustably mounted on said base so that it can be tilted to a position in relation to the ball the user wishes to practise or simulate, i.e. an uphill, or downhill lie and/or standing above, or below the ball, drive means (11, 12) being provided for tilting the platform to a selected position. Advantageously, two marked areas (14) are provided corresponding to the user's foot positions, and pressure responsive devices are provided for detecting the weight distribution between the respective feet, signals from which are fed during a golfing swing to comparator means, and thence to indicator means (17) for showing the percentage of bodyweight taken by each foot during a swing.
Patent AU-629685-B2 (AU)
Title: Amplifying with directly coupled, cascaded amplifiers
Inventor: ALLFATHER LARS P
IPC: H03F3/217
Filed: 1990-09-10
Granted: 1992-10-08
Abstract: A signal is amplified with a plurality of amplifiers (12-18), each amplifier having a reference port (22), a reference node (C) coupled to the reference port, and a signal port (22), and each amplifier being supplied by a power source (30-36) with operating potential with respect to the reference node that is coupled to the reference port of that amplifier. The amplifiers (12-18) are cascaded in a manner selected so that the output of a first amplifier (12) (which receives the signal to be amplified at its input port) drives the reference node (22) of a second amplifier (14), and the reference node (22) of the first amplifier (12) provides an input at the signal port (20) of the second amplifier (14), whereby the first and second amplifiers are directly coupled together to amplify the applied signal. <IMAGE>
Patent AU-780341-B2 (AU)
Title: Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone
Inventor: CAMBORDE FRANCOISE
IPC: A61P25/04
Filed: 2000-06-29
Granted: 2005-03-17
Abstract: A method of treating pain with acetaminophen comprises the concurrent administration of buspirone. This combination of agents surprisingly results in a morphine-like analgesic response characterized by rapid onset, greater pain relief, and a longer duration of action.
Patent AU-775745-B2 (AU)
Title: Aluminium-titanium alloy with high specular reflectivity, reflecting coatings comprising same and mirrors and parts comprising said coating
Inventor: MARTIN MICHEL
IPC: C23C14/24
Filed: 2000-07-19
Granted: 2004-08-12
Abstract: The invention concerns a metal alloy based on aluminium and titanium whereof the aluminium content ranges between 80 and 90 atoms per hundred and the titanium content ranges between 10 and 20 atoms per hundred. The invention is characterised in that it is microcrystalline and outside thermodynamic equilibrium, said alloy being thereby resistant to oxidation and corrosion and having at the same time remarkable adhesion to polymer materials. The invention also concerns a reflecting coating of said metal alloy, preferably of thickness ranging between 0.01 and 3  mu m, covered with a protective film, preferably in polymer material. The invention further concerns a special mirror having specular reflectivity not less than about 65 %, good resistance to corrosion and oxidation comprising a substrate, preferably in polymer material supporting the inventive reflecting coating. The invention finally concerns parts comprising such a mirror, such as motor vehicle rear-view mirrors.
Patent AU-699388-B2 (AU)
Title: Improvements to roll stabilisation mechanisms in vehicular suspension systems
Inventor: HEYRING CHRISTOPHER BRIAN
IPC: B60G21/02
Filed: 1996-08-21
Granted: 1998-12-03
Abstract: A vehicular suspension system for a vehicle includes at least one pair of transversely adjacent front surface engaging members and at least one pair of transversely adjacent back surface engaging members for supporting a body of the vehicle. The suspension system further includes a first force transmitting device interconnecting the at least one pair of transversely adjacent front surface engaging members, and a second force transmitting device interconnecting the at least one pair of transversely adjacent back surface engaging members. The force transmitting devices transfer forces between the interconnected surface engaging members. Each force transmitting device includes an adjustment device for progressively varying the magnitude and direction of the force transferred between the associated surface engaging members by the force transmitting devices as a function of the relative positions of and the load applied to at least two pairs of the interconnected surface engaging members. The adjustment devices are functionally linked such that the magnitude and the direction of the force transmitted between associated surface engaging members by each of the force transmitting devices is progressively varied to thereby maintain and return the attitude of the vehicle to a position that is at least substantially parallel to the average surface plane supporting the vehicle.
Patent AU-677340-B2 (AU)
Title: Catalyst support, method for making a precursor gel for a catatyst support
Inventor: DERLETH HELMUT
IPC: C08F10/00
Filed: 1994-05-10
Granted: 1997-04-17
Abstract: Process for the manufacture of a support containing silica and at least one constituent chosen from alumina and aluminum phosphate, according to which an alcohol, water, a silicon alkoxide and an acid are mixed under conditions such that gelling or precipitation of silica is prevented, an acidic solution of an aluminum compound and/or a solution of a source of phosphate ions are added thereto, a gelling agent is added thereto, a gel is recovered which is washed with water and then by means of an organic liquid, the gel is then dried by atomization until a powder is obtained, and the powder is calcined. Polymerization of olefins in the presence of a catalyst containing chromium on a support as described above.
Patent AU-780511-B2 (AU)
Title: Glucosamine and egg for reducing inflammation
Inventor: ADALSTEINSSON ORN
IPC: A61K35/54
Filed: 2000-09-07
Granted: 2005-03-24
Abstract: The invention is directed to a composition and method for the treatment and prevention of inflammation and inflammatory related disorders. The composition is glucosamine in combination with an egg product. It is generally preferred that the egg product is obtained from an avian which has been hyperimmunized with an immunogenic mixture and/or which contains an anti-inflammatory composition.
Patent AU-539342-B2 (AU)
Title: Lighting system
Inventor: HANLET J M
IPC: H01J61/067
Filed: 1981-04-27
Granted: 1984-09-20
Abstract: An improved lighting system (10) which in the preferred embodiment includes a cathode (12) having an external surface (34) being coated with a cathode outside film (40) for emitting electrons therefrom. A first anode (14) extends internal to the cathode (12) for heating the cathode (12) to thereby emit electrons from the external surface (34). A second anode (16) is positionally located external to the enclosed cathode (12) for accelerating the electrons emitted from the cathode external surface (34). A bulb member (18) encompasses the cathode (12), the first anode (14), and the second anode (16) in a hermetic type seal. The bulb member (18) has a predetermined gas composition contained therein with the gas composition atoms being ionized by the cathode emitted electrons. The gas composition ionized atoms radiate in the ultraviolet bandwidth of the electromagnetic spectrum. The bulb member (18) is coated with a fluorescent material (20) for intercepting the ultraviolet energy responsive to the ionization of the gas composition atoms. The fluorescent material (20) radiates in the visible bandwidth of the electromagnetic spectrum to give a visible light output.
Patent AU-640747-B2 (AU)
Title: Process for producing polyacrylic acids
IPC: C09K23/52
Filed: 1991-02-15
Granted: 1993-09-02
Abstract: The invention relates to a process for producing polyacrylic acids and copolymers of acrylic acid with up to 50 mol-% of comonomers. These compounds have a molecular weight of less than 100,000, measured at a pH-value of 8, and 10 to 60 mol-% are neutralized with calcium hydroxide. The invention also relates to the use of these products as grinding and dispersing aids for calcium carbonate.
Patent AU-703394-B2 (AU)
Title: Use of heparinases to decrease inflammatory responses
Inventor: BENNETT D CLARK
IPC: A61K47/48
Filed: 1996-09-27
Granted: 1999-03-25
Abstract: Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.
Patent AU-687087-B2 (AU)
Title: Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
Inventor: AMSCHLER HERMANN
IPC: A61K31/44
Filed: 1994-07-02
Granted: 1998-02-19
Abstract: PCT No. PCT/EP94/02169 Sec. 371 Date Dec. 19, 1995 Sec. 102(e) Date Dec. 19, 1995 PCT Filed Jul. 2, 1994 PCT Pub. No. WO95/01338 PCT Pub. Date Jan. 12, 1995Compounds of formula (I), in which one of the substituents R1 or R2 stands for hydrogen, 1-6C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, benzyloxy or totally or partially fluorine-substituted 1-4C-alkoxy, and the other stands for totally or partially fluorine-substituted 1-4C-alkoxy, and R3 stands for phenyl, pyridyl, R31, R32 and R33-substituted phenyl or R34, R35, R36 and R37-substituted pyridyl, in which R31 stands for hydroxy, halogen, cyano, carboxyl, trifluoromethyl 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl, 1-4C-alkylcarbonyl, 1-4C-alkylcarbonyloxy, amino, mono- or di-1-4C-alkylamino or 1-4C-alkylcarbonylamino; R32 stands for hydrogen, hydroxy, halogen, amino, trifluoromethyl, 1-4C-alkyl or 1-4C-alkoxy; R33 stands for hydrogen, halogen, 1-4C-alkyl or 1-4C-alkoxy; R34 stands for hydroxy, halogen, cyano, carboxyl, 1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxycarbonyl or amino; R35 stands for hydrogen, halogen, amino or 1-4C-alkyl; R36 stands for hydrogen or halogen; and R37 stands for hydrogen or halogen. These compounds constitute new effective bronchotherapeutic drugs.
Patent AU-740475-B2 (AU)
Title: The use of 1,2,4-triazolo(1,5-c)pyrimidine heterocyclic analogues for the preparation of medicaments useful for the treatment of cerebrovascular disturbances
Inventor: ONGINI ENNIO
IPC: A61P43/00
Filed: 1998-05-14
Granted: 2001-11-08
Abstract: The present invention relates to the use of 1,2,4-triazolo[1,5-c]pyrimidine heterocyclic analogues for the preparation of medicaments for the treatment of cerebrovascular disorders, such as stroke, brain trauma, cerebral infarction and their neurological sequelae.
Patent AU-694457-B2 (AU)
Title: DNA sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter
Inventor: FROMMER WOLF-BERND
IPC: C12N15/29
Filed: 1994-10-24
Granted: 1998-07-23
Abstract: There are described DNA sequences, that contain the coding region of ammonium transporters, which after introduction in suitable vectors are introduced into the plant genome and lead to the formation of mRNA which makes possible either the formation of new ammonium transporters, or prevents the formation of endogenous ammonium transporters in transgenic plants. There are further described plasmids, bacteria, yeast strains, plant cells and transgenic plants, which contain the sequences of ammonium transporters as a constituent of a recombinant DNA, and also a process for the identification and isolation of DNA sequences, coding for ammonium transporters.
Patent AU-560651-B2 (AU)
Title: Modified nucleotides
Inventor: WARD DAVID C
IPC: C12Q1/6804
Filed: 1982-04-13
Granted: 1987-04-16
Abstract: Compounds having the structure: <CHEM> wherein B represents a purine, 7-deazapurine, or pyrimidine moiety covalently bonded to the C<1>-position of the sugar moiety, provided that when B is purine or 7-deazapurine, it is attached at the N<9>-position of the purine or 7-deazapurine and when B is pyrimidine, it is attached at the N<1>-position: wherein A represents a moiety consisting of at least three carbon atoms which is capable of forming a detectable complex with a polypeptide when the compound is incorporated into a double-stranded ribonucleic acid, deoxyribonucleic acid duplex, or DNA-RNA hybrid; wherein the dotted line represents a chemical linkage joining B and A, provided that if B is purine, the linkage is attached to the 8-position of the purine, if B is 7-deazapurine, the linkage is attached to the 7-position of the deazapurine, and if B is pyrimidine, the linkage is attached to the 5-position of the pyrimidine; and  wherein each of x, y and z represents <CHEM> either directly, or when incorporated into oligo- and polynucleotides, provide probes which are widely useful. Applications include detection and localization of polynucleotide sequences in chromosomes, fixed cells, tissue sections, and cell extracts. Specific applications include chromosomal karyotyping, clinical diagnosis of nucleic acid-containing etiological agents, e.g. bacteria, viruses, or fungi, and diagnosis of genetic disorders.
Patent AU-550099-B2 (AU)
Title: Digital transmission
Inventor: CATCHPOLE RICHARD JOHN
IPC: H04L25/03
Filed: 1982-05-31
Granted: 1986-03-06
Abstract: Feedback equalization is employed for digital repeaters of transmission systems having twisted-wire pairs, in order to reduce intersymbol interference while minimizing near-end crosstalk gain. Previously the incoming signal was selectively amplified at the higher frequencies in order to negate intersymbol interference, with subsequent near-end crosstalk gain. According to the present invention the intersymbol interference element of an incoming signal is cancelled, prior to amplification in an adder by a compensation signal derived from the output signal of a regenerator and a retimer. An output stage serves to amplify and shape the resultant signal to a form suitable for transmission. The compensation signal comprises the inverted output of a filtering and scaling network.
Patent AU-549717-B2 (AU)
Title: Device and method for automatically checking microprocessor- controlled electric apparatus, particularly in motor vehicles
Inventor: DENZ H GROSCHEL W KAISER G KRA
IPC: E06C7/18
Filed: 1982-07-15
Granted: 1986-02-06
Abstract: PCT No. PCT/DE82/00149 Sec. 371 Date Aug. 24, 1983 Sec. 102(e) Date Aug. 24, 1983 PCT Filed Jul. 15, 1982 PCT Pub. No. WO83/02836 PCT Pub. Date Aug. 18, 1983.A method is proposed for self-monitoring of microcomputer-controlled network devices (10) in motor vehicles which in accordance with applied transducer signals execute specified functions and upon detecting an error store a corresponding data word in memory. For indicating the error, the data word is converted into a signal train or voltage and detected by means of voltage measurement. This is preferably accomplished by inserting a diagnosis insert-plug (42) between the transducer lines and the network device (10). A voltmeter (47) can be connected to this test adapter and indicates this signal train or voltage. A specific type of error is associated with a specific voltage. As a result, a diagnosis which is as detailed as desired, of a complicated system, can be performed with a simple voltmeter (47) available in commerce.
Patent AU-785240-B2 (AU)
Title: Novel bee venom polypeptides and methods of use thereof
Inventor: SPERTINI FRANCOIS
IPC: A61K38/00
Filed: 2001-02-16
Granted: 2006-11-23
Abstract: The present invention provides novel protein named Api m 6. Api m 6 was identified in bee venom and is found in four isoforms, each about 8kD. The purified Api m 6 can be used to modulate immune responses, e.g. in individuals hypersensitive to bee venom.
Patent AU-641832-B2 (AU)
Title: Process for producing bread dough
Inventor: NASU HIDEO
IPC: A21D8/02
Filed: 1991-11-29
Granted: 1993-09-30
Abstract: A process for producing bread dough in a very short time, which comprises the first step of kneading 40 to 80 parts by weight of flour, 30 to 80 parts by weight of water, provided that the amount of water does not exceed that of flour, and a suitable amount of yeast to such an extent that the weakening of dough begins within 5 minutes as determined by the resistograph of the mixture, and the second step of adding to the mixture, immediately or after leaving the mixture as such to cause fermentation, such an amount of flour that the total amount thereof will reach 100 parts by weight and, if necessary, a suitable amount of water to continue kneading. When an acid is added in the first step to regulate the pH of the kneaded mixture to 4 to 5 and a salt is added in the second step to regulate the pH of the kneaded dough to 5 to 6, the obtained dough has excellent elasticity and the bread produced therefrom has a high mechanical strength. When a reducing agent, amylase, emulsifier or oxidizing agent is added in the first or second step, the obtained dough has improved properties.